Mesa Laboratories (MLAB) EBITDA (2010 - 2025)

Mesa Laboratories has disclosed EBITDA across 16 years of filings, most recently posting $8.0 million for Q4 2025.

• EBITDA for Q4 2025 came in at $8.0 million, up 38.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.1 million (up 100.84% YoY), and the FY2025 annual result was $1.3 million, up 100.46% from the prior year.
• EBITDA came in at $8.0 million for Q4 2025 at Mesa Laboratories, up from $4.7 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $8.0 million in Q4 2025 to a low of -$271.3 million in Q1 2024.
• The 5-year median for EBITDA is $3.1 million (2021), against an average of -$12.5 million.
• Across the five-year window, EBITDA sank 11518.18% in 2021 and surged 8725.37% in 2024, its largest moves.
• Mesa Laboratories' EBITDA stood at -$2.5 million in 2021, then soared by 235.43% to $3.4 million in 2022, then plunged by 101.97% to -$67000.0 in 2023, then soared by 8725.37% to $5.8 million in 2024, then surged by 38.0% to $8.0 million in 2025.
• The last three EBITDA figures came in at $8.0 million (Q4 2025), $4.7 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.